Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Profit After Tax: 2009-2024

Historic Profit After Tax for Pediatrix Medical (MD) over the last 16 years, with FY2024 value amounting to -$99.1 million.

  • Pediatrix Medical's Profit After Tax rose 26884.93% to $71.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $162.2 million, marking a year-over-year increase of 16389.36%. This contributed to the annual value of -$99.1 million for FY2024, which is 6399.98% down from last year.
  • Per Pediatrix Medical's latest filing, its Profit After Tax stood at -$99.1 million for FY2024, which was down 6399.98% from -$60.4 million recorded in FY2023.
  • Pediatrix Medical's Profit After Tax's 5-year high stood at $131.0 million during FY2021, with a 5-year trough of -$796.5 million in FY2020.
  • In the last 5 years, Pediatrix Medical's Profit After Tax had a median value of -$60.4 million in 2023 and averaged -$151.7 million.
  • As far as peak fluctuations go, Pediatrix Medical's Profit After Tax soared by 11644.27% in 2021, and later tumbled by 19106.5% in 2023.
  • Annual analysis of 5 years shows Pediatrix Medical's Profit After Tax stood at -$796.5 million in 2020, then surged by 116.44% to $131.0 million in 2021, then tumbled by 49.35% to $66.3 million in 2022, then crashed by 191.07% to -$60.4 million in 2023, then plummeted by 64.0% to -$99.1 million in 2024.
  • Its Profit After Tax stands at -$99.1 million for FY2024, versus -$60.4 million for FY2023 and $66.3 million for FY2022.